glucagon has been researched along with Cystic Fibrosis in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (36.11) | 18.7374 |
| 1990's | 4 (11.11) | 18.2507 |
| 2000's | 1 (2.78) | 29.6817 |
| 2010's | 9 (25.00) | 24.3611 |
| 2020's | 9 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Alessio, DA; De Leon, DD; Doliba, A; Eiel, JN; Flatt, AJ; Gallagher, K; Gallop, R; Hadjiliadis, D; Kelly, A; Nyirjesy, SC; Peleckis, AJ; Rickels, MR; Rubenstein, RC; Sheikh, S; Stefanovski, D; Tami, A | 1 |
| Behn, CGD; Chan, CL; Finn, E; Garrish, J; Nadeau, KJ; Pyle, L; Sagel, SD; Severn, C; Vigers, T; Zeitler, PS | 1 |
| Almdal, TP; Faurholt-Jepsen, D; Katzenstein, TL; Krogh-Madsen, R; Mathiesen, IHM; Møller, R; Nielsen, BU; Pressler, T; Rickels, MR; Ritz, C; Shaw, JAM; Stefanovski, D | 1 |
| De Leon, DD; Hadjiliadis, D; Kelly, A; Kilberg, MJ; Kubrak, C; Rickels, MR; Rubenstein, RC; Sheikh, S; Stefanovski, D | 1 |
| Balliro, CA; Damiano, ER; El-Khatib, FH; Jafri, RZ; Putman, MS; Russell, SJ; Sherwood, JS; Zheng, H | 1 |
| Cuchel, M; Hadjiliadis, D; Harris, C; Kelly, A; Kilberg, MJ; Kubrak, C; Rickels, MR; Rubenstein, RC; Sheikh, S; Stefanovski, D | 1 |
| Armaghanian, N; Brand-Miller, J; Chua, EL; Hetherington, J; Markovic, TP; Parameswaran, V; Steinbeck, K | 1 |
| Anini, Y; Chappe, F; Chappe, V; Semaniakou, A | 1 |
| De Leon, DD; Eiel, JN; Gallop, R; Hadjiliadis, D; Kelly, A; Localio, R; Nyirjesy, SC; Peleckis, AJ; Rickels, MR; Rubenstein, RC; Sheikh, S; Sidhaye, A; Stefanovski, D | 1 |
| Chan, HC; Chung, YW; Guo, JH; Huang, WQ; Ruan, YC; Yu, MK; Zhang, XH | 1 |
| Deutsch, GH; Fligner, CL; Frevert, CW; Gibson, RL; Hull, RL; McNamara, S; Ramsey, BW; Sanda, S | 1 |
| Aramandla, R; Babon, JAB; Balamurugan, AN; Bautista, A; Bottino, R; Brissova, M; Bush, WS; Dadi, PK; Dai, C; DeNicola, ME; Drumm, ML; Fayolle, C; Hart, NJ; Jacobson, DA; Kent, SC; MacDonald, PE; Poffenberger, G; Powers, AC; Prasad, N; Spigelman, AF; Thames, AH | 1 |
| Couper, JJ; Horowitz, M; Kritas, S; Martin, AJ; Perano, SJ; Rayner, CK; Sullivan, T | 1 |
| Engelhardt, JF; Gibson-Corley, K; Hara, M; He, N; Liang, B; Norris, AW; Ode, KL; Philipson, LH; Sun, X; Tyler, SR; Uc, A; Wang, K; Xie, W; Yi, Y | 1 |
| Cuchel, M; De Leon, DD; Gudipaty, L; Hadjiliadis, D; Kelly, A; Kubrak, C; Malik, S; Nyirjesy, SC; Peleckis, AJ; Rickels, MR; Rosenfeld, NK; Rubenstein, RC; Sheikh, S; Stefanovski, D | 1 |
| Edlund, A; Eliasson, L; Flodström-Tullberg, M; Lindqvist, A; Pedersen, MG; Wierup, N | 1 |
| Chapman, I; Greville, H; Hetzel, D; Horowitz, M; Jones, KL; Kuo, P; Maddox, A; Rayner, CK; Russo, A; Stevens, JE; Wishart, JM | 1 |
| Engelhardt, JF; Evans, TI; Fisher, JT; Hu, S; Keiser, NW; Lei, D; Li, G; Liang, B; Meyerholz, DK; Norris, AW; Olivier, AK; Stewart, ZA; Sui, H; Sun, X; Wang, K; Xie, W; Yan, Z; Yi, Y; Zhou, W | 1 |
| Edenborough, FP; Mackie, AD; Thornton, SJ | 1 |
| Geffner, ME; Gillard, BK; Itami, RM; Kaplan, SA; Levin, SR; Lippe, BM; Taylor, IL | 2 |
| Buchanan, KD; Craig, BG; Johnston, CF; Kerr, JI; Redmond, AO | 1 |
| Adrian, TE; Allen, JM; Batten, JC; Bloom, SR; Hodson, ME; Lee, YC; Penketh, AR; Sarson, DL | 1 |
| Hinds, A; Parsons, HG; Sheehan, AG | 1 |
| Holst, JJ; Koch, C; Lanng, S; Nerup, J; Orskov, C; Røder, ME; Thorsteinsson, B | 1 |
| Dooley, RR; Lippe, BM; Sperling, MA | 1 |
| Buchanan, KD; Redmond, AO; Trimble, ER | 1 |
| Hinds, A; Machida, H; Parsons, HG; Sheehan, AG | 1 |
| Diem, P; Klein, DJ; Levitt, MD; Moran, A; Robertson, RP | 1 |
| Bawab, W; Boué, A; Chastre, E; Emami, S; Faure, C; Gespach, C; Muller, F | 1 |
| Abdul-Karim, FW; Dahms, BB; Rodman, HM; Velasco, ME | 1 |
| Landing, BH; Soejima, K | 1 |
| Girard, J; Ronen, G; Rutishauser, M; Stahl, M | 1 |
| Girard, J; Nars, PW; Rutishauser, M; Stahl, M; Zuppinger, K | 1 |
| Milner, AD | 1 |
| Carpenter, DF; Di Sant' Agnese, P; Gorden, P; Handwerger, S; Peter, G; Roth, J | 1 |
2 review(s) available for glucagon and Cystic Fibrosis
| Article | Year |
|---|---|
Cystic fibrosis-related diabetes.
Topics: Administration, Oral; Breast Feeding; Cystic Fibrosis; Diabetes Mellitus; Diabetic Angiopathies; Dietary Supplements; Female; Glucagon; Glucose; Glucose Intolerance; Humans; Insulin; Islets of Langerhans; Lipid Metabolism; Lung Transplantation; Nutritional Physiological Phenomena; Pregnancy; Pregnancy in Diabetics; Prognosis; Proteins | 2003 |
The diffuse endocrine system in cystic fibrosis.
Topics: Atrophy; Cystic Fibrosis; Diabetes Mellitus; Endocrine Glands; Food; Gastric Inhibitory Polypeptide; Glucagon; Histocytochemistry; Humans; Insulin; Jejunum; Pancreas; Pancreatic Polypeptide; Vasoactive Intestinal Peptide | 1983 |
4 trial(s) available for glucagon and Cystic Fibrosis
| Article | Year |
|---|---|
Effects of GLP-1 and GIP on Islet Function in Glucose-Intolerant, Pancreatic-Insufficient Cystic Fibrosis.
Topics: Adult; Arginine; Blood Glucose; Cystic Fibrosis; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Incretins; Insulin; Proinsulin | 2022 |
Effect of Sitagliptin on Islet Function in Pancreatic Insufficient Cystic Fibrosis With Abnormal Glucose Tolerance.
Topics: Adolescent; Adult; Cystic Fibrosis; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Exocrine Pancreatic Insufficiency; Female; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin Secretion; Islets of Langerhans; Male; Sitagliptin Phosphate; Young Adult | 2021 |
Pancreatic enzyme supplementation improves the incretin hormone response and attenuates postprandial glycemia in adolescents with cystic fibrosis: a randomized crossover trial.
Topics: Adolescent; Blood Glucose; Child; Cross-Over Studies; Cystic Fibrosis; Enzyme Replacement Therapy; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Insulin; Male; Pancrelipase; Postprandial Period | 2014 |
Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation.
Topics: Adult; Blood Glucose; Cystic Fibrosis; Dietary Carbohydrates; Dietary Fats; Double-Blind Method; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Incretins; Insulin; Lipase; Male; Pancreas; Young Adult | 2011 |
30 other study(ies) available for glucagon and Cystic Fibrosis
| Article | Year |
|---|---|
Hypoglycemia in children and young adults with cystic fibrosis during oral glucose tolerance testing vs. continuous glucose monitoring.
Topics: Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; Child; Cystic Fibrosis; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hypoglycemia; Insulin; Insulin Resistance; Young Adult | 2023 |
Characterization of impaired beta and alpha cell function in response to an oral glucose challenge in cystic fibrosis: a cross-sectional study.
Topics: Adult; Cross-Sectional Studies; Cystic Fibrosis; Glucagon; Glucose; Humans; Hypoglycemia; Proinsulin | 2023 |
Dysregulated insulin in pancreatic insufficient cystic fibrosis with post-prandial hypoglycemia.
Topics: Adolescent; Area Under Curve; Blood Glucose; C-Peptide; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Female; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemia; Incretins; Insulin; Insulin Secretion; Male; Young Adult | 2020 |
Automated glycemic control with the bionic pancreas in cystic fibrosis-related diabetes: A pilot study.
Topics: Adult; Bionics; Blood Glucose; Cost of Illness; Cystic Fibrosis; Diabetes Mellitus; Female; Gastrointestinal Agents; Glucagon; Glycemic Control; Humans; Hypoglycemic Agents; Insulin; Male; Pancreas, Artificial; Patient Satisfaction | 2020 |
Hypoglycemia and Islet Dysfunction Following Oral Glucose Tolerance Testing in Pancreatic-Insufficient Cystic Fibrosis.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Case-Control Studies; Child; Cystic Fibrosis; Female; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemia; Insulin; Insulin Secretion; Islets of Langerhans; Male; Time Factors; Young Adult | 2020 |
Hypoglycemia in cystic fibrosis during an extended oral glucose tolerance test.
Topics: Adolescent; Adult; Blood Glucose; Cystic Fibrosis; Fasting; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemia; Insulin; Male; Young Adult | 2020 |
VIP reduction in the pancreas of F508del homozygous CF mice and early signs of Cystic Fibrosis Related Diabetes (CFRD).
Topics: Animals; Blood Glucose; Cystic Fibrosis; Diabetes Complications; Glucagon; Homozygote; Insulin; Mice; Mice, Inbred C57BL; Mice, Inbred CFTR; Pancreas; Vasoactive Intestinal Peptide | 2021 |
Glucose-Sensitive CFTR Suppresses Glucagon Secretion by Potentiating KATP Channels in Pancreatic Islet α Cells.
Topics: Animals; Calcium; Cell Line; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Gene Expression; Gene Knockdown Techniques; Glucagon; Glucagon-Secreting Cells; Glucose; Glucose Intolerance; KATP Channels; Mice; Mice, Mutant Strains; Mutation | 2017 |
Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure.
Topics: Adolescent; Adult; Body Mass Index; Child; Cystic Fibrosis; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Insulin; Insulin-Secreting Cells; Interleukin-1beta; Lung Transplantation; Male; Pancreas; Pancreatic Polypeptide; Retrospective Studies; Somatostatin; Young Adult | 2018 |
Cystic fibrosis-related diabetes is caused by islet loss and inflammation.
Topics: Adult; Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Diabetes Complications; Diabetes Mellitus; Female; Gene Deletion; Glucagon; Humans; Inflammation; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Male; Mice; Mutation | 2018 |
A Transient Metabolic Recovery from Early Life Glucose Intolerance in Cystic Fibrosis Ferrets Occurs During Pancreatic Remodeling.
Topics: Animals; Blood Glucose; Cystic Fibrosis; Cytokines; Female; Ferrets; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Hyperglycemia; Insulin; Insulin Resistance; Male; Pancreas | 2016 |
Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance.
Topics: Adolescent; Adult; C-Peptide; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin-Secreting Cells; Male; Middle Aged; Pancreas; Proinsulin; Young Adult | 2017 |
CFTR is involved in the regulation of glucagon secretion in human and rodent alpha cells.
Topics: Animals; Cells, Cultured; Colforsin; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Glucagon; Glucagon-Secreting Cells; Glucose; Humans; Male; Membrane Potentials; Mice; Middle Aged; Mutation; Somatostatin-Secreting Cells | 2017 |
Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets.
Topics: Animals; Animals, Newborn; Apoptosis; Cells, Cultured; Cystic Fibrosis; Diabetes Mellitus; Dilatation, Pathologic; Disease Models, Animal; Disease Progression; Female; Ferrets; Fibrosis; Gene Knockout Techniques; Glucagon; Glucose; Glucose Intolerance; Hyperglycemia; Insulin; Insulin Secretion; Islets of Langerhans; Male; Pancreas, Exocrine; Pancreatic Ducts; Pancreatitis; Species Specificity | 2012 |
Carbohydrate tolerance in cystic fibrosis is closely linked to pancreatic exocrine function.
Topics: Adult; Amylases; Blood Glucose; Carbohydrates; Cystic Fibrosis; Drug Tolerance; Glucagon; Glucose Tolerance Test; Humans; Injections, Intravenous; Insulin; Islets of Langerhans; Isoenzymes; Pancreas; Tolbutamide | 1984 |
Insulin resistance in a young man with cystic fibrosis.
Topics: Adolescent; Cystic Fibrosis; Gastric Inhibitory Polypeptide; Glucagon; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Male; Obesity; Receptor, Insulin | 1984 |
Adult cystic fibrosis: postprandial response of gut regulatory peptides.
Topics: Adult; Cholecystokinin; Cystic Fibrosis; Female; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Humans; Male; Neurotensin; Pancreatic Polypeptide | 1983 |
Tolbutamide causes a modest increase in insulin secretion in cystic fibrosis patients with impaired glucose tolerance.
Topics: Administration, Oral; Adolescent; Adult; C-Peptide; Cystic Fibrosis; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Infusions, Intravenous; Insulin; Insulin Secretion; Male; Tolbutamide | 1995 |
Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.
Topics: Administration, Oral; Adult; C-Peptide; Cystic Fibrosis; Diabetes Complications; Diabetes Mellitus; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glucose Tolerance Test; Hormones; Humans; Injections, Intravenous; Insulin; Intestinal Mucosa; Intestines; Male; Middle Aged; Pancreas; Pancreatic Polypeptide; Peptide Fragments; Proinsulin; Protein Precursors; Time Factors | 1993 |
Pancreatic alpha and beta cell functions in cystic fibrosis.
Topics: Adolescent; Adult; Arginine; Child; Cystic Fibrosis; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Prediabetic State | 1977 |
Insulin and glucagon response to arginine infusion in cystic fibrosis.
Topics: Arginine; Blood Glucose; Body Height; Body Weight; Child; Child, Preschool; Cystic Fibrosis; Fasting; Female; Glucagon; Humans; Injections, Intravenous; Insulin; Insulin Secretion; Male | 1977 |
Postprandial hyperglycemia and pancreatic function in cystic fibrosis patients.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Cystic Fibrosis; Eating; Female; Forced Expiratory Flow Rates; Gastric Inhibitory Polypeptide; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperglycemia; Insulin; Insulin Secretion; Islets of Langerhans; Male; Reference Values; Time Factors | 1991 |
Pancreatic endocrine function in cystic fibrosis.
Topics: Adult; Arginine; C-Peptide; Cystic Fibrosis; Fasting; Glucagon; Glucose Tolerance Test; Humans; Hyperglycemia; Hypoglycemia; Insulin; Pancreas; Pancreatic Polypeptide; Time Factors | 1991 |
Vasoactive intestinal peptide and its receptors in fetuses with cystic fibrosis.
Topics: Adenylyl Cyclases; Cystic Fibrosis; Female; Fetus; Glucagon; Humans; Intestinal Mucosa; Intestine, Small; Liver; Male; Muscle, Smooth; Pancreas; Pregnancy; Receptors, Gastrointestinal Hormone; Receptors, Vasoactive Intestinal Peptide; Reference Values; Vasoactive Intestinal Peptide | 1989 |
Islets of Langerhans in adolescents and adults with cystic fibrosis. A quantitative study.
Topics: Adolescent; Adult; Age Factors; Child; Cystic Fibrosis; Diabetes Mellitus, Type 1; Female; Glucagon; Humans; Hyperglycemia; Immunoenzyme Techniques; Insulin; Islets of Langerhans; Male; Somatostatin | 1986 |
Pancreatic islets in older patients with cystic fibrosis with and without diabetes mellitus: morphometric and immunocytologic studies.
Topics: Adolescent; Adult; Child; Cystic Fibrosis; Diabetes Mellitus, Type 1; Epithelium; Female; Glucagon; Humans; Hypertrophy; Immunoenzyme Techniques; Insulin; Islets of Langerhans; Male; Pancreatic Diseases; Somatostatin | 1986 |
[Arginine test for the examination of endocrine pancreatic function in childhood].
Topics: Adolescent; Anorexia Nervosa; Arginine; Blood Glucose; Child; Child, Preschool; Cystic Fibrosis; Fasting; Female; Glucagon; Humans; Injections, Intravenous; Insulin; Islets of Langerhans; Methods; Pancreatic Diseases | 1974 |
Endocrine function of the pancreas in cystic fibrosis: evidence for an impaired glucagon and insulin response following arginine infusion.
Topics: Adolescent; Antigens; Arginine; Blood Glucose; Child; Child, Preschool; Cystic Fibrosis; Female; Glucagon; Humans; Insulin; Insulin Secretion; Male; Pancreas | 1974 |
Blood glucose and serum insulin levels in children with cystic fibrosis.
Topics: Adolescent; Blood Glucose; Child; Child, Preschool; Cystic Fibrosis; Diabetes Mellitus; Glucagon; Glucose Tolerance Test; Humans; Infant; Injections, Intravenous; Insulin; Islets of Langerhans; Tolbutamide | 1969 |
Glucose intolerance in cystic fibrosis.
Topics: Adolescent; Adult; Blood Glucose; Child; Cystic Fibrosis; Diabetes Mellitus; Diabetes Mellitus, Type 1; Glucagon; Glucose; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Islets of Langerhans; Pancreas; Phentolamine; Tolbutamide | 1969 |